agilon health, inc. (NYSE:AGL) Shares Sold by Nuveen Asset Management LLC

Nuveen Asset Management LLC cut its holdings in agilon health, inc. (NYSE:AGL - Free Report) by 53.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 816,635 shares of the company's stock after selling 953,074 shares during the period. Nuveen Asset Management LLC owned about 0.20% of agilon health worth $1,552,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Capital International Investors raised its position in shares of agilon health by 72.0% in the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company's stock worth $42,431,000 after buying an additional 9,346,295 shares during the period. Millennium Management LLC boosted its stake in agilon health by 187.8% in the fourth quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock valued at $13,704,000 after acquiring an additional 4,706,357 shares during the period. Algert Global LLC raised its holdings in shares of agilon health by 1,042.7% during the fourth quarter. Algert Global LLC now owns 2,108,687 shares of the company's stock valued at $4,007,000 after buying an additional 1,924,157 shares during the last quarter. Charles Schwab Investment Management Inc. increased its stake in shares of agilon health by 49.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company's stock valued at $8,629,000 after acquiring an additional 1,498,524 shares during the period. Finally, Susquehanna Fundamental Investments LLC acquired a new position in shares of agilon health during the fourth quarter valued at approximately $1,616,000.

agilon health Price Performance

Shares of NYSE:AGL traded up $0.05 on Friday, reaching $2.15. The company's stock had a trading volume of 1,888,537 shares, compared to its average volume of 4,971,968. agilon health, inc. has a 52-week low of $1.50 and a 52-week high of $7.73. The company has a market cap of $890.00 million, a P/E ratio of -2.29 and a beta of 0.14. The company has a 50-day simple moving average of $3.57 and a 200 day simple moving average of $3.19. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29.

agilon health (NYSE:AGL - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.03 earnings per share for the quarter, beating analysts' consensus estimates of ($0.01) by $0.04. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The company had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.50 billion. During the same quarter last year, the business posted ($0.02) EPS. The firm's revenue for the quarter was down 4.5% on a year-over-year basis. As a group, equities research analysts anticipate that agilon health, inc. will post -0.59 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. JMP Securities restated a "market perform" rating on shares of agilon health in a report on Monday, April 28th. Citigroup raised shares of agilon health from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $3.25 to $5.00 in a research note on Friday, April 25th. Needham & Company LLC reaffirmed a "hold" rating on shares of agilon health in a research note on Friday, March 21st. Wells Fargo & Company decreased their price target on shares of agilon health from $6.00 to $5.00 and set an "overweight" rating on the stock in a research note on Tuesday, May 13th. Finally, Royal Bank of Canada increased their price target on shares of agilon health from $3.00 to $3.50 and gave the company an "outperform" rating in a research note on Wednesday, February 26th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $4.79.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.